Christopher B. Mead
Since co-founding London & Mead in 1994 after almost six years as a federal prosecutor, Chris has been named as a Fellow in the American College of Trial Lawyers, repeatedly listed as one of the top 100 lawyers in Washington, D.C. by the Washington Post and Washingtonian Magazine, and listed in Super Lawyers and Best Lawyers for civil litigation and white collar criminal defense. Chris has successfully tried dozens of cases to verdict as lead trial counsel. Chris is now of counsel to London & Mead and provides services on legacy cases and counsel regarding ongoing matters. His active practice of law is as a partner with Schertler, Onorato & Mead.
Chris is a repeat instructor for the National Institute of Trial Advocacy (NITA) and co-chair of the Bench/Bar Liaison Committee for the U.S. District Court of Maryland. He is a repeat speaker at conferences on topics including the Food, Drug & Cosmetic Act, health care investigations, whistleblower law, and government contracting.
1985-1986: law clerk to the Honorable Joseph H. Young, U.S. District Judge for the District of Maryland.
1986-1989: associate, Williams & Connolly, Washington, D.C.
1989-1994: Assistant U.S. Attorney for the District of Maryland, specializing in white collar criminal prosecutions. Lead prosecutor in numerous investigations and prosecutions of generic drug companies, and worked extensively with FDA's Special Prosecution Staff and Office of Criminal Investigations. Received FDA Commissioner's Special Citation for Prosecutions of Application and Manufacturing Fraud, and Maryland Governor's Award for Victim Assistance. Lead counsel in multiple trials and appeals before the Fourth Circuit Court of Appeals; extensive experience in money laundering, tax evasion, mail and wire fraud, bank fraud and embezzlement, interstate transportation of stolen property, embezzlement from ERISA plans, threats against the President, kidnapping, narcotics and firearms offenses.
1994: Special Assistant U.S. Attorney, District of Columbia, lead counsel in prosecution of a generic drug executive represented by Fried, Frank, et al. who was convicted after trial of perjury to Congress.